Glioblastoma: Overcoming fundamental biological and delivery barriers to therapy.
The current standard of care is summarized and emerging strategies aimed at overcoming constraints aimed at overcoming these constraints are critically examined, including locoregional delivery technologies, immunotherapy, biomarker-defined precision approaches, and adaptive clinical trial designs.